Supplementary Table S1 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression

作者：Blanca Rius‐Sansalvador, Anastasia Chrysovalantou Chatziioannou, Pekka Keski‐Rahkonen, Nivonirina Robinot, Ferrán Moratalla-Navarro, Núria Moragas, Elisabet Guinó, Mazda Jenab, Francisco D. Morón-Duran, Carmen Atencia, Gemma Ibáñez‐Sanz, L. Rodriguez Alonso, Alfredo Mata Bilbao, Ana García‐Rodríguez, Hwayoung Noh, E Fryer, R. Zamora-Ros, Olatz Mokoroa, Iosu Delfrade, Saverio Caini, José María Huerta, Thérèse Truong, Gianluca Severi, Yazdan Asgari, ­Rosario ­Tumino, Salvatore Panico, Anne Tjønneland, Agnetha Linn Rostgaard‐Hansen, María‐José Sánchez, Valeria Pala, Fulvio Ricceri, Marc J. Gunter, Vı́ctor Moreno, Mireia Obón‐Santacana · 年份：2026 · DOI：10.1158/1055-9965.33143600 · 研究领域：Medicine、Internal medicine、Oncology、Bioinformatics、Computational biology

<p>Supplementary Table S1. Top-ranked metabolic features associated with colorectal neoplasia progression prior to multiple testing correction. Features with nominal p-values <0.01 from linear trend models across diagnostic groups are shown. Beta coefficients represent the direction and magnitude of association across disease progression. Direction indicates whether metabolite levels increase or decrease with advancing disease stage.</p>